Las Vegas, NV -- (SBWIRE) -- 09/26/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Office Depot Inc (NYSE:ODP), Sunedison Inc (NYSE:SUNE), BioScrip Inc (NASDAQ:BIOS), Pacific Biosciences of California (NASDAQ:PACB)
Office Depot Inc (NYSE:ODP) managed to keep its gain at 1.51% on above-normal volume of 11.49M shares. The stock settled at $4.72 after floating in a range of $4.56 to $4.76. Its latest price has reached market capitalization of $1.36 billion. Its 52-week range has been $2.24 to $6.10. Office Depot, Inc., together with its subsidiaries, supplies office products and services. Its North American Retail division sells an assortment of merchandise, such as general office supplies.
For How Long ODP will fight for Profitability? Read This Trend Analysis report
Sunedison Inc (NYSE:SUNE) traded up on a volume of 10.57 million, higher than its standard daily volume. Shares have gained 4.08% to $8.16. Over the last twelve months, the stock has gained 167.67% and faced a worst price of $2.15. SunEdison Inc, formerly MEMC Electronic Materials, Inc is engaged in the development, manufacture and sale of silicon wafers.
For How Long SUNE’s Gloss will Attract Investors? Find out via this report
BioScrip Inc (NASDAQ:BIOS) settled 8.50% higher at $9.19 on above-normal volume of 9.90M shares during the last trading day. The stock has its 12-month high at $17.62 and 52-week low price was $8.29. It traded in a range of $8.29 to $9.40 during the last trading day. SunEdison, Inc. develops, manufactures, and sells silicon wafers. The company is also involved in developing and selling photovoltaic energy solutions.
Why Should Investors Buy BIOS After the Recent Fall? Just Go Here and Find Out
In the last trading session, Pacific Biosciences of California (NASDAQ:PACB) was up on high volume, trading at a volume of 9.52M versus its average daily volume of 519,383.00 shares. At $5.98, the stock has attained market capitalization of 390.20 million. Pacific Biosciences of California, Inc. develops, manufactures, and markets an integrated platform for genetic analysis.
Will PACB Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimer at: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)